Alzheimer's disease (AD) is a progressive neurodegenerative disease with a complex and
heterogeneous pathophysiology. The number of people living with AD is predicted to …

The Alzheimer center of the VU University Medical Center opened in 2000 and was initiated
to combine both patient care and research. Together, to date, all patients forming the …

Abstract Background Dementia with Lewy bodies (DLB) and Parkinson's disease dementia
(PDD), which share many clinical, neurochemical, and morphological features, have been …

Dementia with Lewy bodies (DLB) and Parkinson's disease-dementia (PDD), although
sharing many clinical, neurochemical and morphological features, according to DSM-5, are …

Although psychosis is a defining feature of Lewy body disease, psychotic symptoms occur in
a subset of patients with every major neurodegenerative disease. Few studies, however …

Parkinson's Disease (PD) and the closely related Dementia with Lewy Bodies (DLB) are due
to the accumulation of pathogenic alpha-synuclein protein in brain cells manifest by …

Importance Plasma phosphorylated tau (p-tau) has proven to be an accurate biomarker for
Alzheimer disease (AD) pathologic characteristics, offering a less expensive and less …

Alzheimer Disease Overview - GeneReviews® - NCBI Bookshelf US flag An official website of
the United States government Here's how you know NIH NLM Logo Access keys NCBI …

Objective In a multicenter cohort of probable dementia with Lewy bodies (DLB), we tested
the hypothesis that β-amyloid and tau biomarker positivity increases with age, which is …

ABSTRACT PD, PD with dementia, and dementia with Lewy bodies are clinical syndromes
characterized by the neuropathological accumulation of alpha‐synuclein in the CNS that …